vs
CORCEPT THERAPEUTICS INC（CORT）与WSFS FINANCIAL CORP（WSFS）财务数据对比。点击上方公司名可切换其他公司
WSFS FINANCIAL CORP的季度营收约是CORCEPT THERAPEUTICS INC的1.4倍（$275.3M vs $202.1M），WSFS FINANCIAL CORP净利率更高（31.5% vs 12.0%，领先19.5%），CORCEPT THERAPEUTICS INC同比增速更快（11.1% vs 7.5%），过去两年CORCEPT THERAPEUTICS INC的营收复合增速更高（17.3% vs 1.7%）
Corcept Therapeutics是一家制药企业，专注于严重代谢疾病、精神疾病及肿瘤疾病治疗药物的发现、开发与商业化。公司围绕皮质醇过量带来的不良影响展开研究，致力于开发可缓解相关症状的新型化合物，管理团队由首席执行官兼总裁、董事Joseph K. Belanoff医学博士领导。
WSFS金融集团是一家金融服务企业，核心子公司WSFS银行是总部位于特拉华州及大特拉华谷地区规模最大、经营历史最久的本地管理银行与财富管理机构。集团共运营115个网点，其中88个为银行网点，分布在宾夕法尼亚、特拉华、新泽西、佛罗里达、弗吉尼亚、内华达六州，提供全面金融服务。
CORT vs WSFS — 直观对比
营收规模更大
WSFS
是对方的1.4倍
$202.1M
营收增速更快
CORT
高出3.6%
7.5%
净利率更高
WSFS
高出19.5%
12.0%
两年增速更快
CORT
近两年复合增速
1.7%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $202.1M | $275.3M |
| 净利润 | $24.3M | $86.8M |
| 毛利率 | 98.7% | — |
| 营业利润率 | 2.2% | — |
| 净利率 | 12.0% | 31.5% |
| 营收同比 | 11.1% | 7.5% |
| 净利润同比 | -21.0% | 31.7% |
| 每股收益（稀释后） | $0.20 | $1.64 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CORTWSFS
| Q1 26 | — | $275.3M | ||
| Q4 25 | $202.1M | $271.9M | ||
| Q3 25 | $207.6M | $270.5M | ||
| Q2 25 | $194.4M | $267.5M | ||
| Q1 25 | $157.2M | $256.1M | ||
| Q4 24 | $181.9M | $261.5M | ||
| Q3 24 | $182.5M | $267.7M | ||
| Q2 24 | $163.8M | $266.0M |
净利润CORTWSFS
| Q1 26 | — | $86.8M | ||
| Q4 25 | $24.3M | $72.7M | ||
| Q3 25 | $19.7M | $76.4M | ||
| Q2 25 | $35.1M | $72.3M | ||
| Q1 25 | $20.5M | $65.9M | ||
| Q4 24 | $30.7M | $64.2M | ||
| Q3 24 | $47.2M | $64.4M | ||
| Q2 24 | $35.5M | $69.3M |
毛利率CORTWSFS
| Q1 26 | — | — | ||
| Q4 25 | 98.7% | — | ||
| Q3 25 | 97.8% | — | ||
| Q2 25 | 98.2% | — | ||
| Q1 25 | 98.5% | — | ||
| Q4 24 | 98.4% | — | ||
| Q3 24 | 98.4% | — | ||
| Q2 24 | 98.5% | — |
营业利润率CORTWSFS
| Q1 26 | — | — | ||
| Q4 25 | 2.2% | 35.8% | ||
| Q3 25 | 4.9% | 37.3% | ||
| Q2 25 | 13.7% | 35.7% | ||
| Q1 25 | 2.2% | 34.0% | ||
| Q4 24 | 13.9% | 32.3% | ||
| Q3 24 | 25.5% | 31.9% | ||
| Q2 24 | 21.7% | 34.0% |
净利率CORTWSFS
| Q1 26 | — | 31.5% | ||
| Q4 25 | 12.0% | 26.7% | ||
| Q3 25 | 9.5% | 28.3% | ||
| Q2 25 | 18.1% | 27.0% | ||
| Q1 25 | 13.1% | 25.7% | ||
| Q4 24 | 16.9% | 24.6% | ||
| Q3 24 | 25.9% | 24.1% | ||
| Q2 24 | 21.7% | 26.0% |
每股收益（稀释后）CORTWSFS
| Q1 26 | — | $1.64 | ||
| Q4 25 | $0.20 | $1.33 | ||
| Q3 25 | $0.16 | $1.37 | ||
| Q2 25 | $0.29 | $1.27 | ||
| Q1 25 | $0.17 | $1.12 | ||
| Q4 24 | $0.25 | $1.08 | ||
| Q3 24 | $0.41 | $1.08 | ||
| Q2 24 | $0.32 | $1.16 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $372.2M | — |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $647.8M | $2.7B |
| 总资产 | $836.7M | $22.1B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资CORTWSFS
| Q1 26 | — | — | ||
| Q4 25 | $372.2M | $1.7B | ||
| Q3 25 | $421.7M | — | ||
| Q2 25 | $342.2M | — | ||
| Q1 25 | $322.8M | — | ||
| Q4 24 | $383.3M | $1.2B | ||
| Q3 24 | $380.3M | — | ||
| Q2 24 | $473.2M | — |
股东权益CORTWSFS
| Q1 26 | — | $2.7B | ||
| Q4 25 | $647.8M | $2.7B | ||
| Q3 25 | $631.9M | $2.8B | ||
| Q2 25 | $635.8M | $2.7B | ||
| Q1 25 | $683.3M | $2.7B | ||
| Q4 24 | $679.6M | $2.6B | ||
| Q3 24 | $638.8M | $2.7B | ||
| Q2 24 | $596.2M | $2.5B |
总资产CORTWSFS
| Q1 26 | — | $22.1B | ||
| Q4 25 | $836.7M | $21.3B | ||
| Q3 25 | $823.6M | $20.8B | ||
| Q2 25 | $801.7M | $20.8B | ||
| Q1 25 | $846.5M | $20.5B | ||
| Q4 24 | $840.6M | $20.8B | ||
| Q3 24 | $784.3M | $20.9B | ||
| Q2 24 | $714.6M | $20.7B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $38.4M | — |
| 自由现金流经营现金流 - 资本支出 | $38.4M | — |
| 自由现金流率自由现金流/营收 | 19.0% | — |
| 资本支出强度资本支出/营收 | 0.0% | — |
| 现金转化率经营现金流/净利润 | 1.58× | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流CORTWSFS
| Q1 26 | — | — | ||
| Q4 25 | $38.4M | $220.0M | ||
| Q3 25 | $54.5M | $121.5M | ||
| Q2 25 | $43.9M | $37.2M | ||
| Q1 25 | $5.1M | $8.7M | ||
| Q4 24 | $59.3M | $219.9M | ||
| Q3 24 | $73.8M | $3.1M | ||
| Q2 24 | $41.2M | $44.8M |
自由现金流CORTWSFS
| Q1 26 | — | — | ||
| Q4 25 | $38.4M | $213.6M | ||
| Q3 25 | — | $120.3M | ||
| Q2 25 | $43.9M | $35.2M | ||
| Q1 25 | $5.0M | $6.3M | ||
| Q4 24 | $59.2M | $205.6M | ||
| Q3 24 | $72.2M | $-489.0K | ||
| Q2 24 | $40.8M | $42.1M |
自由现金流率CORTWSFS
| Q1 26 | — | — | ||
| Q4 25 | 19.0% | 78.6% | ||
| Q3 25 | — | 44.5% | ||
| Q2 25 | 22.6% | 13.2% | ||
| Q1 25 | 3.2% | 2.5% | ||
| Q4 24 | 32.5% | 78.6% | ||
| Q3 24 | 39.5% | -0.2% | ||
| Q2 24 | 24.9% | 15.8% |
资本支出强度CORTWSFS
| Q1 26 | — | — | ||
| Q4 25 | 0.0% | 2.3% | ||
| Q3 25 | 0.0% | 0.5% | ||
| Q2 25 | 0.0% | 0.7% | ||
| Q1 25 | 0.1% | 0.9% | ||
| Q4 24 | 0.1% | 5.5% | ||
| Q3 24 | 0.9% | 1.4% | ||
| Q2 24 | 0.3% | 1.0% |
现金转化率CORTWSFS
| Q1 26 | — | — | ||
| Q4 25 | 1.58× | 3.03× | ||
| Q3 25 | 2.77× | 1.59× | ||
| Q2 25 | 1.25× | 0.51× | ||
| Q1 25 | 0.25× | 0.13× | ||
| Q4 24 | 1.93× | 3.43× | ||
| Q3 24 | 1.56× | 0.05× | ||
| Q2 24 | 1.16× | 0.65× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
